Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03EZR
|
|||
| Former ID |
DIB009854
|
|||
| Drug Name |
CMD-003
|
|||
| Indication | Lymphoma [ICD-11: 2A80-2A86; ICD-9: 202.8, 208.9] | Phase 2 | [1] | |
| Non-hodgkin lymphoma [ICD-11: 2B33.5; ICD-10: C85.9] | Phase 2 | [2] | ||
| Company |
Cell medica
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01948180) Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.